Secondary Malignant Neoplasm — Trials

Secondary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,275
Recruiting: 2,321
Ph III recruiting: 272
Growth YoY: +12.3%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,961)

clinicaltrialsPublishedShowing 801–850 of 1,225 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05490472	JAB-2485 Activity in Adult Patients With Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	102	Jacobio Pharmaceuticals Co., Ltd.INDUSTRY	2	Jan 9, 2026	clinicaltrials
NCT06831149	Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction	recruiting	Phase 2	225	Matthew SpectorOTHER	1	Jan 9, 2026	clinicaltrials